[Metabolic effects of Catapres].
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D004837:Epinephrine / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000378:metabolism*; D006003:Glycogen / Q000378:metabolism*; D006943:Hyperglycemia / Q000139:chemically induced; D007093:Imidazoles / Q000494:pharmacology*; D007773:Lactates / Q000097:blood; D050356:Lipid Metabolism; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D009132:Muscles / Q000378:metabolism; D009539:Nicotinic Acids / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D011984:Sensory Receptor Cells / Q000187:drug effects; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology; D014043:Tolazoline / Q000494:pharmacology
D000959:Antihypertensive Agents; D002247:Carbon Isotopes; D005230:Fatty Acids, Nonesterified; D007093:Imidazoles; D007773:Lactates; D008112:Liver Glycogen; D009539:Nicotinic Acids; D013565:Sympatholytics; D002245:Carbon Dioxide; D012110:Reserpine; D006003:Glycogen; D014043:Tolazoline; D005947:Glucose; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine
Stoffwechseleffekte des Catapresan.